版本:
中国

BRIEF-Cadila Healthcare's Zydus gets final FDA nod for anti-hypertensive tablets

April 25 Cadila Healthcare Ltd

* Says Zydus receives final approval from USFDA for olmesartan medoxomil tablets

* Says drug is an anti-hypertensive to be produced at group manufacturing facility in Ahmedabad Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐